| URL | http://www.cleveland.com/business/index.ssf/2017/1 |
| Source | Cleveland.com |
| Date Published | 11/27/2017 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Xellia Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 70 |
| Year reshoring announced: | 2017 |
| Year reshoring implemented or to be implemented: | 2018 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | Denmark |
| City reshored to: | Bedford |
| State(s) reshored to: | OH |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals |